Roswell Park Cancer Institute: all 417 studies

Page 2 of 5. Open to participants first (64), then studies with results posted, then the rest; newest registration first within each.

• SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaActive, not recruitingNCT02455557Phase 2Results posted
• Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation TherapyTerminatedNCT02452463Phase 2Results posted
• Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsCompletedNCT02399215Phase 2Results posted
• Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal CancerCompletedNCT02393755Phase 1/2Results posted
• Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney CancerTerminatedNCT02170389Not applicableResults posted
• DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in RemissionCompletedNCT02166905Phase 1/2Results posted
• Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT02159950Phase 2Results posted
• Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck CancerTerminatedNCT02068157Phase 2Results posted
• Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaTerminatedNCT02029417Phase 2Results posted
• Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell LymphomaActive, not recruitingNCT01959698Phase 1Results posted
• Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy RegimensCompletedNCT01948141Phase 2Results posted
• Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by SurgeryCompletedNCT01886235Not applicableResults posted
• Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung CancerCompletedNCT01876446Phase 2Results posted
• Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01835223Phase 1/2Results posted
• Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current SmokersCompletedNCT01771627Not applicableResults posted
• Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing SurgeryTerminatedNCT01754519Phase 2Results posted
• Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone LymphomaCompletedNCT01682044Phase 2Results posted
• Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation TherapyTerminatedNCT01682031Phase 2Results posted
• Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic LeukemiaTerminatedNCT01649791Not applicableResults posted
• Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib TosylateTerminatedNCT01582009Phase 1/2Results posted
• Rasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesTerminatedNCT01564277Phase 2Results posted
• Cholecalciferol and Flu Vaccine in Treating Healthy ParticipantsTerminatedNCT01561989Not applicableResults posted
• Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal CancerTerminatedNCT01545141Phase 1/2Results posted
• Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom MacroglobulinemiaTerminatedNCT01536067Phase 2Results posted
• Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by SurgeryTerminatedNCT01533948Phase 2Results posted
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT01529827Phase 2Results posted
• Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT01527149Phase 2Results posted
• High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal CancerTerminatedNCT01198548Phase 2Results posted
• Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerCompletedNCT01178944Phase 2Results posted
• Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing SurgeryTerminatedNCT01108003Not applicableResults posted
• Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer PatientsCompletedNCT01027416Not applicableResults posted
• A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile DuctsCompletedNCT01007552Phase 2Results posted
• Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus IrinotecanTerminatedNCT01004159Phase 2Results posted
• Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate CancerCompletedNCT00970203Phase 2Results posted
• Acceptability of Less Harmful Alternatives to CigarettesCompletedNCT00957424Not applicableResults posted
• Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00942266Phase 2Results posted
• Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck CancerTerminatedNCT00891904Not applicableResults posted
• Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing ObservationCompletedNCT00887432Not applicableResults posted
• Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersCompletedNCT00856388Not applicableResults posted
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to TreatmentTerminatedNCT00851552Phase 2Results posted
• Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney CancerCompletedNCT00849186Not applicableResults posted
• Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerCompletedNCT00843726Phase 2Results posted
• An Alternative Dosing Schedule of Varenicline for Smoking CessationCompletedNCT00835900Phase 2Results posted
• Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaTerminatedNCT00814164Phase 2Results posted
• Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00736645Phase 2Results posted
• Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung CancerCompletedNCT00690924Not applicableResults posted
• Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerTerminatedNCT00683787Phase 2Results posted
• Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal AdenocarcinomaTerminatedNCT00625183Phase 2Results posted
• Flaxseed, Aromatase Inhibitors and Breast Tumor CharacteristicsCompletedNCT00612560Not applicableResults posted
• Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate CancerTerminatedNCT00536991Phase 1/2Results posted
• High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00536601Not applicableResults posted
• Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell TransplantCompletedNCT00534118Not applicableResults posted
• Bupropion in Helping Adults Stop SmokingCompletedNCT00534001Phase 2Results posted
• Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or ThroatTerminatedNCT00530088Not applicableResults posted
• Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air PassagesTerminatedNCT00528775Phase 2Results posted
• Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT00526890Phase 2Results posted
• Vitamin D in Treating Patients With Prostate CancerCompletedNCT00524680Phase 2Results posted
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00524589Phase 2Results posted
• Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic KeratosisTerminatedNCT00524485Not applicableResults posted
• Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00524459Phase 2Results posted
• Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryTerminatedNCT00524316Phase 2Results posted
• Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00524121Phase 2Results posted
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple MyelomaCompletedNCT00523848Phase 2Results posted
• Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic CancerTerminatedNCT00470535Phase 2Results posted
• Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal CancerCompletedNCT00470184Phase 2Results posted
• Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial CancerTerminatedNCT00470067Phase 2Results posted
• Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00248495Phase 2Results posted
• Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00244985Phase 1/2Results posted
• Fulvestrant in Treating Patients With Recurrent Prostate CancerTerminatedNCT00217464Phase 2Results posted
• Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal CancerTerminatedNCT00107315Phase 2Results posted
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic CancerCompletedNCT00100815Phase 2Results posted
• Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00096044Phase 2Results posted
• Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic LeukemiaCompletedNCT00096018Phase 1/2Results posted
• Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the ProstateTerminatedNCT00084864Phase 2Results posted
• NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersCompletedNCT00053989Phase 2Results posted
• Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerCompletedNCT00003816Phase 2/3Results posted
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003270Phase 2Results posted
• Photodynamic Therapy in Treating Patients With Skin CancerCompletedNCT00002975Phase 2Results posted
• Text Message and Mail Delivery of Tailored Educational Materials to Improve Access to Resources for Smoking Cessation of Menthol Tobacco CigarettesActive, not recruitingNCT07857681Not applicable
• Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple MyelomaWithdrawnNCT07082270Phase 1
• A Food Security Intervention for the Prevention of Cancer in Low-income FamiliesSuspendedNCT07039630Not applicable
• Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular CarcinomaSuspendedNCT06968195Phase 1
• Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung CancerWithdrawnNCT06943664Phase 2
• Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell TransplantationActive, not recruitingNCT06798701Not applicable
• ivWatch in Prevention of Extravasation of Vesicants in an Oncology SettingCompletedNCT06758011Not applicable
• Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue SarcomaWithdrawnNCT06670976Phase 1
• Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With CancerTerminatedNCT06456411Not applicable
• An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung CancerWithdrawnNCT06427369Phase 1
• An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their CaregiversActive, not recruitingNCT06414317Not applicable
• Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic MalignanciesTerminatedNCT06343376Phase 1
• Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT06305598Phase 1
• Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary CareActive, not recruitingNCT06256718Not applicable
• FL118 for Treating Patients With Advanced Pancreatic Ductal AdenocarcinomaWithdrawnNCT06206876Phase 1
• EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal CancerActive, not recruitingNCT06011772Early Phase 1
• Financial Health Educational Program for Increasing Financial Literacy Among Underserved Communities in Western New YorkCompletedNCT05997589Not applicable
• Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette SmokersCompletedNCT05825001Not applicable
• Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active SurveillanceCompletedNCT05764330Not applicable
• A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationWithdrawnNCT05589844Phase 1
• Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication AdherenceCompletedNCT05587582
• Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast CancerWithdrawnNCT05539365Phase 2

← Roswell Park Cancer Institute overview and focus areas